<DOC>
	<DOCNO>NCT00234559</DOCNO>
	<brief_summary>The purpose study determine : 1 . If vacuum assist closure ( VAC® ) therapy result alter proteomic expression angiogenic marker compare moist wound therapy . 2 . If VAC® therapy result increase angiogenesis compare moist wound therapy .</brief_summary>
	<brief_title>Trial Vacuum Assisted Closure® Therapy Versus Control Therapy Angiogenesis</brief_title>
	<detailed_description />
	<criteria>Patient male female &gt; 18 year old . Patient patient 's legal authorized representative willing sign inform consent . Patient post surgical dehisce wound low extremity longer two week less one month . Patient transcutaneous oximetry ( TcPO2 ) evaluation demonstrate tissue hypoxia periwound region , indicate reading 1040 mmHg within prior two week . Ankle Brachial Index &gt; 0.7 within prior two week . Patient pregnant ( pregnancy test negative ) nonlactating Visit 1 . Patient plan become pregnant course study . Patient willing use effective method contraception duration study , permanently sterilize , postmenopausal define cessation menses least one year prior enrollment study . Diagnosed untreated wound infection . Poor nutrition status evidence prealbumin &lt; 12mg/dl within past 30 day extracellular mass &lt; 95 % . Presence sickle cell disease . Presence connective tissue disease ( e.g . history active lupus ) . Hemoglobin A1c ( HbA1c ) level great 9 % thirty day prior screen visit ( patient confirm diabetic ) . Treatment investigational therapy within previous 30 day . Lower extremity wound ( consideration study ) malignancy . Lower extremity wound ( consideration study ) untreatable cellulitis . Presence untreated osteomyelitis . Presence systemic hematologic disorder condition would impede healing . History radiation wind area . History drug may delay wound heal . History thermal injury wound area . Prior VAC® therapy wound within 30 day enrollment . Current prior treatment hyperbaric oxygen therapy ( HBO ) warmup therapy wound . Recent diagnosis cancer active management cancer within last year . Treatment skin dermal substitute dressing live cell capable produce growth factor within previous 30 day . End stage renal disease . History alcohol drug abuse may impact protocol compliance delay wound heal . Known hypersensitivity hydrogel disposable component VAC® Therapy System . Necrotic tissue eschar present debrided . Any severe concurrent disease , , judgment investigator , would make patient inappropriate entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Angiogenesis</keyword>
	<keyword>Post surgical dehisce wound low extremity</keyword>
</DOC>